Integra Lifesciences Holdings Corp (NASDAQ:IART)
| 41.31 Delayed Data As of Dec 07 |  +0.38 / +0.93%Today’s Change | 33.44 Today|||52-Week Range 60.69 | -26.32% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $3.2B |
Company Description
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Contact Information
Integra LifeSciences Holdings Corp. 1100 Campus Road Princeton New Jersey 08540 |
Employees
Shareholders
| Mutual fund holders | 48.66% |
| Other institutional | 38.62% |
| Individual stakeholders | 22.27% |
Top Executives
| Jan D. de Witte | President, Chief Executive Officer & Director |
| Steve Leonard | Vice President-Global Operations & Supply Chain |
| Lea Daniels Knight | Chief Financial Officer & Executive Vice President |
| Stuart Hart | Chief Medical Officer & Vice President |
| Robert T. Davis | Executive VP & President-Tissue Technologies |
